PARP1 and ovarian carcinoma: In a notable study by Kim et al., exosomes derived from ovarian cancer were successfully employed as carriers for CRISPR/Cas9 DNA to effectively suppress the expression of poly (ADP-ribose) polymerase 1(PARP-1) in a xenograft mouse model (187).